Intra-Cellular Therapies Inc - BRDR

BSP:I2TC34 (USA)   BRDR
R$ 84.24 (0%) Dec 12
At Loss
P/B:
7.72
Market Cap:
R$ 8.93B ($ 1.48B)
Enterprise V:
R$ 3.04B ($ 495.88M)
Volume:
-
Avg Vol (2M):
643.00
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
643.00

Business Description

Intra-Cellular Therapies Inc
NAICS : 325412 SIC : 2834
ISIN : BRI2TCBDR009

Share Class Description:

BSP:I2TC34: BRDR
Description
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
Name Current Vs Industry Vs History
Cash-To-Debt 56.84
Equity-to-Asset 0.86
Debt-to-Equity 0.02
Debt-to-EBITDA -0.15
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 29.02
Distress
Grey
Safe
Beneish M-Score 90.8
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 40.25
9-Day RSI 61.09
14-Day RSI 72.94
6-1 Month Momentum % 68.3
12-1 Month Momentum % 68.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.66
Quick Ratio 7.51
Cash Ratio 6.06
Days Inventory 176.4
Days Sales Outstanding 76.14
Days Payable 94.97

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.2
Shareholder Yield % 0.01

Financials (Next Earnings Date:2025-02-21 Est.)

BSP:I2TC34's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Intra-Cellular Therapies Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil R$) 3,204.287
EPS (TTM) (R$) -0.753
Beta 0
Volatility % 36.92
14-Day RSI 72.94
14-Day ATR (R$) 0.342941
20-Day SMA (R$) 84.148
12-1 Month Momentum % 68.3
52-Week Range (R$) 49.53 - 85.98
Shares Outstanding (Mil) 106.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Intra-Cellular Therapies Inc Filings

Filing Date Document Date Form
No Filing Data

Intra-Cellular Therapies Inc Stock Events

Financials Calendars
Event Date Price(R$)
No Event Data

Intra-Cellular Therapies Inc Frequently Asked Questions

What is Intra-Cellular Therapies Inc(BSP:I2TC34)'s stock price today?
The current price of BSP:I2TC34 is R$84.24. The 52 week high of BSP:I2TC34 is R$85.98 and 52 week low is R$49.53.
When is next earnings date of Intra-Cellular Therapies Inc(BSP:I2TC34)?
The next earnings date of Intra-Cellular Therapies Inc(BSP:I2TC34) is 2025-02-21 Est..
Does Intra-Cellular Therapies Inc(BSP:I2TC34) pay dividends? If so, how much?
Intra-Cellular Therapies Inc(BSP:I2TC34) does not pay dividend.

Press Release

Subject Date
No Press Release